NCT01656538View on ClinicalTrials.gov

A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

February 20, 2013

Primary Completion Date

November 18, 2016

Study Completion Date

February 14, 2018

Conditions
Metastatic Breast Cancer
Interventions
DRUG

Paclitaxel

DRUG

Reolysin

Trial Locations (7)

V1Y 5L3

BCCA - Cancer Centre for the Southern Interior, Kelowna

V5Z 4E6

BCCA - Vancouver Cancer Centre, Vancouver

V8R 6V5

BCCA - Vancouver Island Cancer Centre, Victoria

L8V 5C2

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton

K7L 5P9

Cancer Centre of Southeastern Ontario at Kingston, Kingston

K1H 8L6

Ottawa Hospital Research Institute, Ottawa

S4T 7T1

Allan Blair Cancer Centre, Regina

Sponsors

Collaborators (1)

Oncolytics Biotech
All Listed Sponsors
collaborator

Oncolytics Biotech

INDUSTRY

lead

Canadian Cancer Trials Group

NETWORK

NCT01656538 - A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter